|
Abbreviation
|
Definition
|
| ICI |
Immune Checkpoint Inhibitor |
| PD |
Programmed Death (e.g., PD-1, PD-L1) |
| CTLA |
Cytotoxic T-Lymphocyte Antigen |
| NK |
Natural Killer Cell |
| NSCLC |
Non-Small-Cell Lung Cancer |
| HCC |
Hepatocellular Carcinoma |
| CRC |
Colorectal Cancer |
| RCC |
Renal Cell Carcinoma |
| GI |
Gastrointestinal |
| FMT |
Fecal Microbiota Transplantation |
| SCFA |
Short-Chain Fatty Acid |
| LPS |
Lipopolysaccharide |
| GUS |
Gut Microbial /-glucuronidases |
| PFS |
Progression-Free Survival |
| OS |
Overall Survival |
| RCT |
Randomized Controlled Trial |
| TME |
Tumor Microenvironment |
| NAFLD |
Non-Alcoholic Fatty Liver Disease |
| IL |
Interleukin |